JPMORGAN CHASE & CO - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$21,808,440
-54.8%
26,500
-60.5%
0.00%
-60.0%
Q2 2023$48,214,034
+291.2%
67,100
+347.3%
0.01%
+150.0%
Q1 2023$12,325,000
+474486.1%
15,000
+316.7%
0.00%
Q4 2022$2,597
-99.9%
3,600
+16.1%
0.00%
Q3 2022$2,135,000
+16.5%
3,1000.0%0.00%
Q2 2022$1,833,000
-15.3%
3,1000.0%0.00%
Q1 2022$2,165,000
-80.1%
3,100
-86.2%
0.00%
-100.0%
Q4 2020$10,870,000
-17.6%
22,500
-2.2%
0.00%0.0%
Q3 2020$13,193,000
-6.0%
23,000
+2.2%
0.00%
-33.3%
Q2 2020$14,032,000
-21.3%
22,500
-38.4%
0.00%
-25.0%
Q1 2020$17,823,000
-34.3%
36,500
-49.5%
0.00%
-20.0%
Q4 2019$27,147,000
+67.0%
72,300
+23.4%
0.01%
+66.7%
Q3 2019$16,256,000
+5.9%
58,600
+18.6%
0.00%0.0%
Q2 2019$15,347,000
-4.4%
49,400
+26.3%
0.00%0.0%
Q1 2019$16,055,000
-82.1%
39,100
-83.7%
0.00%
-85.7%
Q4 2018$89,491,000
+3.5%
239,600
+12.0%
0.02%
+23.5%
Q3 2018$86,465,000
+8.5%
214,000
-7.4%
0.02%
+6.2%
Q2 2018$79,693,000
+34.2%
231,000
+34.0%
0.02%
+23.1%
Q1 2018$59,368,000
+46.9%
172,400
+60.4%
0.01%
+44.4%
Q4 2017$40,416,000
-1.2%
107,500
+14.4%
0.01%0.0%
Q3 2017$40,900,000
+167.8%
94,000
+202.3%
0.01%
+200.0%
Q2 2017$15,274,000
+35.4%
31,100
+6.9%
0.00%0.0%
Q1 2017$11,277,000
-30.8%
29,100
-3.0%
0.00%
-25.0%
Q4 2015$16,286,000
+16.7%
30,0000.0%0.00%0.0%
Q3 2015$13,954,00030,0000.00%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 72,600$42,916,0000.05%
JANE STREET GROUP, LLC 74,600$44,098,0000.02%
GROUP ONE TRADING, L.P. 11,800$6,975,0000.01%
HRT FINANCIAL LP 700$413,0000.01%
Allianz Asset Management GmbH 1,500$887,0000.00%
JPMORGAN CHASE & CO 3,100$1,833,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders